Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine (PCTKA)
Postoperative Pain Management, Total Knee Arthroplasty
About this trial
This is an interventional treatment trial for Postoperative Pain Management focused on measuring Pregabalin, Celecoxib, Intrathecal morphine, Total knee arthroplasty
Eligibility Criteria
Inclusion Criteria:
- Patients between 50-75 years of age
- Patients with an American Society of Anesthesiologists physical status of I to III
- Patients scheduled for primary TKA with a diagnosis of osteoarthritis under spinal anesthesia
Exclusion Criteria:.
- Patients had a known allergy to any of the medications being used
- a history of drug or alcohol abuse
- a history of taking chronic pain medications (ie, show-release preparations of opioids, given that morphine consumption was the primary outcome)
- a history of taking pregabalin or gabapentin / non-steroidal anti-inflammatory drugs / COX-2 inhibitors
- a psychiatric disorder
- a history of impaired renal function (Cr > 1.5 mg/dl), peptic ulcer, asthma, thrombotic cerebrocardiovascular diseases, uncontrolled hypertension
- a history of contraindication for spinal anesthesia
- a history of bleeding tendency
- pregnancy
- unable or unwilling to use patient - controlled analgesic (PCA)
Sites / Locations
- Supranee Niruthisard
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Pregabalin
Celecoxib
Pregabalin with celecoxib
Placebo
Oral single-dose of pregabalin (150 mg) and 1 capsule of placebo (P) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.
Oral single-dose of celecoxib (400 mg) and 1 capsule of placebo (C) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.
Oral single-dose of pregabalin (150 mg) and celecoxib (400 mg) (PC) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.
Oral single-dose of placebo 2 capsules 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg